MSL, Women's Health

United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, Medical Devices, PharmaceuticalsIndustries

Requirements

Candidates must possess Board Certification in Genetic Counseling, with a Master's Degree in Genetic Counseling or an equivalent from an ABGC-approved program. Experience in prenatal genetic counseling is preferred. The role requires strong analytical, problem-solving, and strategic thinking skills, along with exceptional interpersonal, written, and verbal communication abilities. Flexibility, adaptability, and the capacity to build and maintain relationships across all organizational levels and externally are essential.

Responsibilities

The Medical Science Liaison (MSL) will serve as a scientific and clinical resource for healthcare professionals in Women's Health, providing in-depth education on Natera's reproductive health testing products through presentations. This role involves extensive travel (75% weekly) for in-person customer meetings, managing relationships with Key Opinion Leaders (KOLs), and supporting Natera's Sales and Marketing teams. The MSL will also represent Natera at scientific congresses, support clinical trial initiatives, and maintain up-to-date scientific and clinical expertise.

Skills

Medical Science Liaison

Women's Health

Scientific Presentations

Clinical Presentations

Reproductive Health Testing

Non-invasive Prenatal Testing

Genetic Testing

Hereditary Cancer Testing

Key Opinion Leader (KOL) Management

Clinical Trials

Research Initiatives

Medical Affairs

Scientific Communication

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free